Home > Study Info > Common Questions

Common Questions

Our list of commonly asked questions by people who are thinking about volunteering for a clinical trial.

Why volunteer to join a clinical trial?

By taking part in a clinical trial, you can try a new treatment that may or may not be better than those that already exist. You can also help others better understand how the treatment works in people of different races and genders.

Without volunteers new treatments cannot be developed for future. First and foremost, all participants receive a free consultation and second opinion regarding the disease or disorder and the treatments being tested at no obligation.

If you join a clinical trial, ongoing medical evaluations such as physical examinations, laboratory tests, EKGs and others will be conducted to monitor your general health and well-being.

Finally, there is a possibility that the medicine or treatment being tested may relieve your disease or symptoms.

How much will it cost to participate in a clinical trial?

There is no cost to those who volunteer to participate in a clinical trial. In most clinical trials there will be some monetary compensation to cover the incidental cost for gas, parking and other expenses incurred by enrolled participants.

What are the risks associated with participating in clinical trials?

Risk is present in using all medical treatments including medicines and devices. Clinical trials are designed to assess these risks before any medicine is approved for general use in America.

Since not all risks are known when testing new medical treatments, medical ethics committees review all new clinical trials and require that all potential patients/subjects are fully made aware in writing (called written informed consent) of all risks that are known to be associated with the test medicine or device.

Additionally, all new information regarding safety must to be presented in writing so that participants are fully aware of new risks as they become known. It is the right of each participant to join a trial voluntarily or to continue in a trial based on up-to-date information about risks.

Who should consider joining a clinical trials and why?

It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people because different people may respond differently to treatments. FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials.

Some people participate in clinical trials because they have exhausted standard (approved) treatment options which either did not work for them, or they were unable to tolerate certain side effects. Clinical trials may provide another option when standard therapy has failed.

Other people participate in trials because the want to contribute to the advancement of medical knowledge.

For each clinical trial, researchers develop eligibility criteria, such as the age, sex, type and stage of disease, previous treatment history, and other medical conditions. These criteria help to reduce the amount of variation in the study, without threatening the scientific integrity of the trial, by removing medical variations that might complicate analyzing the results.

Not everyone who applies for a clinical trial will be accepted. Volunteers may be excluded based on the eligibility criteria and/or the number of participants needed by the researchers to collect enough information to determine the safety and effectiveness of a therapeutic agent.

Are clinical trials safe?

The FDA works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial. The federal government has regulations and guidelines for clinical research to protect participants for unreasonable risks.

Although efforts are made to control the risks to clinical trial participants, some risks may be unavoidable because of the uncertainty inherent in medical research studies involving new medical treatments.

The government requires researchers to give prospective participants complete and accurate information about what will happen during the trial. Participants must sign an informed consent document before joining the study indicating they understand that the trial is research, and that they can leave the clinical trial at any time. This informed consent is part of a process that ensures a prospective participant in a clinical trial understands what known risks might be associated with the study, and whether there are potential, but as yet unknown risks that may be associated with the product being studied. This information permits someone deciding whether or not to enter a clinical trial to make an informed decision about the level of risk they are willing to accept before they enter the trial.

What kind of care will I receive?

Clinical trials require experts in specific fields to conduct each trial. For example, new heart medications usually require a cardiologist to conduct the trial. Psychiatric medication trials, such as those conducted at Neuro Behavioral Clinical Research, require trained psychiatrists and psychologists.

Clinical trials will provide medical care and related benefits in the unlikely event you are harmed by participating in a clinical trial, as highlighted in the written informed consent.

How long do the studies last?

Clinical trials can range in length from few weeks to one or more years depending on each situation. Follow-up care to achieve stabilization post-participation in a trial is available for one to two months, on a case by case basis at no cost to you.

How to join a clinical trial

Start by calling Neuro Behavioral Clinical Research at 330-493-1118 or send us an email. You will be given general information about NBCR, our locations, medical and other staff.

We cannot qualify you to participate in a study by phone.

In general, you need to be in good health and not have uncontrolled a major medical illness such as diabetes, hypertension, seizures or cancer. Participants may not have active alcohol or drug abuse problems.

Qualification to participate in a clinical trial is based on medical and psychological interviews, and the review of specific written informed consents. Following an agreement to participate, medical procedures such as physical examination, laboratory tests, EKGs, and more, will be conducted.

This type of comprehensive evaluation usually takes 3 to 4 hours. Before your evaluation, we request that you have fasted for 8 hours (no food, only water allowed) before your appointment so that the required laboratory tests such can be accurately measured.

Clinical trials can range in length from few weeks to one or more years depending on each situation. Follow-up care to achieve stabilization post-participation in a trial is available for one to two months, on a case by case basis at no cost to you.